Marksans Pharma Ltd
Marksans Pharma is engaged in Business of Formulation of pharmaceutical products.
- Market Cap ₹ 2,327 Cr.
- Current Price ₹ 56.8
- High / Low ₹ 66.2 / 9.85
- Stock P/E 13.5
- Book Value ₹ 18.0
- Dividend Yield 0.18 %
- ROCE 25.6 %
- ROE 20.5 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- The company has delivered a poor growth of 7.32% over past five years.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
218 | 199 | 235 | 269 | 248 | 247 | 245 | 256 | 288 | 335 | 331 | 356 | |
190 | 195 | 200 | 232 | 212 | 232 | 213 | 223 | 240 | 266 | 261 | 273 | |
Operating Profit | 29 | 4 | 35 | 37 | 36 | 16 | 32 | 34 | 47 | 69 | 70 | 83 |
OPM % | 13% | 2% | 15% | 14% | 15% | 6% | 13% | 13% | 16% | 21% | 21% | 23% |
Other Income | 0 | -0 | 3 | -1 | 0 | 10 | 2 | 8 | 0 | 0 | 0 | 4 |
Interest | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
Depreciation | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 5 | 7 | 10 | 7 | 19 |
Profit before tax | 21 | -6 | 30 | 28 | 30 | 17 | 28 | 34 | 38 | 58 | 61 | 66 |
Tax % | 18% | -14% | 18% | 26% | 15% | 41% | 19% | 23% | 23% | 26% | 20% | 23% |
Net Profit | 17 | -6 | 25 | 21 | 25 | 10 | 22 | 26 | 30 | 43 | 49 | 51 |
EPS in Rs | 0.41 | -0.16 | 0.61 | 0.50 | 0.61 | 0.24 | 0.55 | 0.63 | 0.72 | 1.04 | 1.21 | 1.24 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
356 | 359 | 305 | 356 | 438 | 630 | 797 | 893 | 767 | 913 | 1,000 | 1,134 | 1,311 | |
334 | 336 | 378 | 455 | 369 | 512 | 612 | 757 | 722 | 834 | 868 | 942 | 1,041 | |
Operating Profit | 22 | 24 | -73 | -100 | 69 | 118 | 185 | 136 | 45 | 78 | 132 | 192 | 270 |
OPM % | 6% | 7% | -24% | -28% | 16% | 19% | 23% | 15% | 6% | 9% | 13% | 17% | 21% |
Other Income | 8 | 2 | -78 | 2 | 4 | 4 | 3 | 9 | 7 | 8 | 5 | 0 | 4 |
Interest | 21 | 19 | 44 | 54 | 15 | 19 | 16 | 10 | 7 | 10 | 10 | 9 | 7 |
Depreciation | 15 | 15 | 20 | 24 | 16 | 16 | 16 | 28 | 30 | 27 | 23 | 27 | 43 |
Profit before tax | -7 | -9 | -215 | -175 | 44 | 86 | 156 | 107 | 15 | 50 | 104 | 157 | 223 |
Tax % | -14% | -4% | -3% | -1% | -12% | 15% | 28% | 23% | 24% | 28% | 23% | 23% | |
Net Profit | -8 | -10 | -223 | -179 | 46 | 72 | 109 | 79 | 9 | 33 | 76 | 117 | 172 |
EPS in Rs | 1.19 | 1.87 | 2.67 | 1.92 | 0.22 | 0.80 | 1.87 | 2.86 | 4.21 | ||||
Dividend Payout % | -7% | -0% | -0% | -0% | 10% | 5% | 4% | 21% | 23% | 6% | 3% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 7% |
3 Years: | 14% |
TTM: | 31% |
Compounded Profit Growth | |
---|---|
10 Years: | 31% |
5 Years: | 2% |
3 Years: | 120% |
TTM: | 107% |
Stock Price CAGR | |
---|---|
10 Years: | 33% |
5 Years: | -1% |
3 Years: | 9% |
1 Year: | 189% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 15% |
Last Year: | 20% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50 | 50 | 50 | 50 | 52 | 52 | 53 | 53 | 41 | 41 | 41 | 41 | 41 | |
Reserves | 100 | 111 | -115 | -220 | 34 | 90 | 326 | 401 | 392 | 430 | 502 | 595 | 698 |
Borrowings | 397 | 424 | 135 | 179 | 163 | 160 | 89 | 88 | 110 | 118 | 100 | 19 | 22 |
108 | 86 | 436 | 389 | 165 | 202 | 220 | 192 | 209 | 142 | 160 | 241 | 293 | |
Total Liabilities | 642 | 658 | 492 | 385 | 401 | 490 | 676 | 722 | 752 | 731 | 802 | 896 | 1,054 |
380 | 392 | 279 | 165 | 156 | 146 | 166 | 270 | 267 | 279 | 270 | 303 | 303 | |
CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 |
Investments | -0 | 10 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
261 | 256 | 213 | 220 | 245 | 344 | 510 | 452 | 484 | 451 | 533 | 593 | 751 | |
Total Assets | 642 | 658 | 492 | 385 | 401 | 490 | 676 | 722 | 752 | 731 | 802 | 896 | 1,054 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20 | 17 | -65 | -62 | 39 | 65 | 155 | 31 | 14 | 50 | 27 | 210 | |
-118 | -35 | 25 | -3 | -5 | -4 | -33 | -123 | -21 | -39 | -13 | -60 | |
59 | 32 | 36 | 57 | -40 | -29 | 17 | -58 | -3 | 3 | -21 | -90 | |
Net Cash Flow | -39 | 13 | -5 | -9 | -7 | 31 | 138 | -150 | -10 | 15 | -7 | 60 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 3% | 2% | -28% | -306% | 45% | 38% | 45% | 23% | 4% | 11% | 19% | 26% |
Debtor Days | 104 | 96 | 118 | 116 | 109 | 98 | 84 | 89 | 118 | 71 | 64 | 78 |
Inventory Turnover | 1.93 | 2.35 | 1.42 | 3.10 | 3.43 | 4.17 | 3.91 | 3.51 | 2.64 | 2.62 | 2.00 | 2.09 |
Documents
Add documentRecent announcements
- Shareholding for the Period Ended December 31, 2020 13 Jan
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 9 Jan
- Closure of Trading Window 31 Dec
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 25 Nov 2020
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2013 from nse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2011 from nse
- Financial Year 2010 from bse
- Financial Year 2010 from nse